GL1X · GenesisL1 explorer

MolNFT v1 · #98190 · protein

Covalent modification of transthyretin K15 by yielding the fluorescent conjugate (E)-3-(dimethylamino)-5-(4-hydroxy-3,5-dimethylstyryl) benzamide

4L1S: “Covalent modification of transthyretin K15 by yielding the fluorescent conjugate…”. X-ray diffraction, 1 ligand (1W4), 1 pocket (best druggability 0.32). MolNFT v1 #98190 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
4L1S
Type
protein
Length
231 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transthyretin
UniProt
P02766
Ligands
1W4
Pockets
1 · best druggability 0.32

Structure

x-ray diffraction · 2 distinct chains · 7% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATransthyretinprotein1167% helix, 53% strandP02766
BTransthyretinprotein1157% helix, 53% strandP02766

Ligands and binding sites

  • 1W4 · S-(4-fluorophenyl) 3-(dimethylamino)-5-[(E)-2-(4-hydroxy-3,5-dimethylphenyl)ethenyl]benzenecarbothioate · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1700.320.7517empty

Interfaces

1 interface between chains.

  • A–B · 931 Ų buried · 18 hydrogen bonds · protein-protein

Compared structures

  • 4L1S · Covalent modification of transthyretin K15 by yielding the fluorescent conjugate… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.